BREVETTI, GREGORIO
 Distribuzione geografica
Continente #
NA - Nord America 1.439
AS - Asia 1.329
EU - Europa 1.232
SA - Sud America 180
AF - Africa 22
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.205
Nazione #
US - Stati Uniti d'America 1.388
SG - Singapore 801
RU - Federazione Russa 587
CN - Cina 294
BR - Brasile 148
UA - Ucraina 148
DE - Germania 109
IT - Italia 107
HK - Hong Kong 85
VN - Vietnam 81
FI - Finlandia 72
NL - Olanda 51
SE - Svezia 37
GB - Regno Unito 35
CA - Canada 27
FR - Francia 25
IE - Irlanda 19
AR - Argentina 14
MX - Messico 14
IN - India 12
PL - Polonia 11
BD - Bangladesh 10
AT - Austria 8
ES - Italia 8
CI - Costa d'Avorio 7
ZA - Sudafrica 7
EC - Ecuador 6
ID - Indonesia 6
JP - Giappone 6
IR - Iran 5
TR - Turchia 5
IQ - Iraq 4
VE - Venezuela 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
HN - Honduras 3
LT - Lituania 3
LV - Lettonia 3
PE - Perù 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
DO - Repubblica Dominicana 2
JO - Giordania 2
OM - Oman 2
TN - Tunisia 2
UZ - Uzbekistan 2
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BF - Burkina Faso 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
CL - Cile 1
DK - Danimarca 1
GR - Grecia 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LU - Lussemburgo 1
MA - Marocco 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
PS - Palestinian Territory 1
PT - Portogallo 1
SD - Sudan 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.205
Città #
Singapore 365
Chandler 199
Moscow 167
Jacksonville 164
Beijing 93
Hong Kong 85
Santa Clara 77
Ashburn 61
Princeton 52
Boston 46
Amsterdam 45
Los Angeles 44
Millbury 40
Wilmington 34
Ho Chi Minh City 33
Munich 31
Nanjing 30
Buffalo 26
Dallas 22
The Dalles 20
New York 17
Hanoi 16
Houston 16
Boydton 14
Turku 13
Boardman 11
Nanchang 11
Ottawa 11
São Paulo 11
Warsaw 10
Kronberg 9
Naples 9
Brooklyn 8
Falls Church 8
Frankfurt am Main 8
Hebei 8
Tianjin 8
Campobasso 7
Chennai 7
Redondo Beach 7
Atlanta 6
Falkenstein 6
Hefei 6
Helsinki 6
Mexico City 6
Montreal 6
Norwalk 6
Nuremberg 6
Rio de Janeiro 6
Tokyo 6
Toronto 6
Chicago 5
Kunming 5
Napoli 5
Seattle 5
Shenyang 5
Belo Horizonte 4
Campinas 4
Da Nang 4
Denver 4
Hải Dương 4
Jiaxing 4
Johannesburg 4
Orange 4
Phoenix 4
Querétaro 4
Baghdad 3
Baku 3
Betim 3
Changsha 3
Curitiba 3
Hangzhou 3
Jakarta 3
London 3
Mumbai 3
Orem 3
Salt Lake City 3
San Mateo 3
Stockholm 3
São Gonçalo 3
Vienna 3
Amman 2
Annapolis 2
Asunción 2
Augusta 2
Baltimore 2
Bexley 2
Birmingham 2
Biên Hòa 2
Brasília 2
Charlotte 2
Cologno Monzese 2
Columbia 2
Criciúma 2
Dearborn 2
Des Moines 2
Düsseldorf 2
El Progreso 2
Fontenay-aux-Roses 2
Franca 2
Totale 2.057
Nome #
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues. 127
Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease. 120
Aortic valve sclerosis in patients with peripheral and/or coronary arterial disease. 119
Inhibition of platelet-activating factor synthesis in human neutrophils and platelets by propionyl-L-carnitine. 116
Metabolic syndrome in peripheral arterial disease: relationship with severity of peripheral circulatory insufficiency, inflammatory status, and cardiovascular comorbidity. 115
Effect of propionylcarnitine on changes in endothelial function and plasma levels of adhesion molecules induced by acute exercise in patients with intermittent claudication 113
L’IMPIANTO DI STENT NELLE ARTERIE DEGLI ARTI INFERIORI RIDUCE IL RISCHIO CARDIOVASCOLARE IN PAZIENTI CON ATEROSCLEROSI PLURIDISTRETTUALE. 108
Cellular adhesion molecules and peripheral arterial disease 106
Functional status measured by walking impairment questionnaire and cardiovascular risk prediction in peripheral arterial disease: results of the Peripheral Arteriopathy and Cardiovascular Events (PACE) study 103
Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index 100
Peripheral arterial disease and cardiovascular risk in Italy. Results of the Peripheral Arteriopathy and Cardiovascular Events (PACE) study 99
Increased inflammatory status and higher prevalence of three-vessel coronary artery disease in patients with concomitant coronary and peripheral atherosclerosis 98
Early vascular alterations in acromegaly 95
Intermittent claudication in Italy. The Peripheral Arteriopathy and Cardiovascular Events (PACE) study 94
Effects of Ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease. 94
IGF system and peripheral arterial disease: relationship with disease severity and inflammatory status of the affected limb. 91
Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease 90
Inflammatory status and endothelial function in asymptomatic and symptomatic peripheral arterial disease. 89
Peripheral arterial disease: the magnitude of the problem and its socioeconomic impact. 89
Adhesion molecules and cardiovascular risk in peripheral arterial disease. Soluble vascular cell adhesion molecule-1 improves risk stratification 89
Mortality in peripheral arterial disease: a comparison of patients managed by vascular specialists and general practitioners. 88
Prevalence of hypoechoic carotid plaques in coronary artery disease: relationship with coexistent peripheral arterial disease and leukocyte number 88
The impact of comorbidity burden on the cardiovascular risk in the Peripheral Arteriopathy and Cardiovascular Events (PACE) study. 85
Effects of AT1 receptor antagonism with candesartan on endothelial function in patients with hypertension and coronary artery disease. 85
Statin therapy in patients with subclinical and evident peripheral artery disease: a meta-analysis 84
IGF system and peripheral arterial disease: relationship with disease severity and inflammatory status of the affected limb 82
Intermittent claudication in older patients: risk factors, cardiovascular comorbidity, and severity of peripheral arterial disease 81
Carnitine-related alterations in patients with intermittent claudication. Indication for a focused carnitine therapy 77
EARLY VASCULAR ALTERATIONS IN ACROMEGALY 76
EUROPEAN MULTICENTER STUDY ON PROPIONYL-L-CARNITINE IN INTERMITTENT CLAUDICATION 74
Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose-titration, multicenter study 74
Endothelial dysfunction: a key to the pathophysiology and natural history of peripheral arterial disease? 74
Intermittent claudication: an historical perspective 72
Exercise increases soluble adhesion molecules ICAM-1 and VCAM-1 in patients with intermitent claudication 72
The prevalence of hypoechoic carotid plaques is greater in peripheral than in coronary artery disease and is related to the neutrophil count 72
Intermittent claudication and endothelial dysfunction 69
Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not with classic risk factors and atheroscloritic burden 67
Microcirculation and tissue metabolism in peripheral arterial disase 67
Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function 67
Women and peripheral arterial disease: same disease, different issues 67
Intermittent Claudication. Pharmacoeconomic and Quality of life aspects of treatment 65
MUSCLE CARNITINE DEFICIENCY IN PATIENTS WITH SEVERE PERIPHERAL VASCULAR DISEASE 62
Vitamin C prevents endothelial dysfunction induced by acute exercise in patients with intermittent claudication 62
High Levels of adhesion molecules are associated with impaired endothelium-mediated vasodilation in patients with peripheral arterial disease 62
Echolucent femoral plaques entail higher risk of echolucent carotid plaques and a more severe inflammatory profile in peripheral arterial disease. 58
Relationship between brachial artery flow-mediated dilation and coronary flow reserve in patients with peripheral artery disease 55
Stent implantation in the arteries of the lower limbs reduces cardiovascular risk in peripheral arterial disease. 55
Infrarenal abdominal aortic aneurysms 54
Metabolic syndrome and cardiovascolar risk prediction in peripheral arterial disease. 52
Effective treatment of orthostatic hypotension by propranolol in the Shy-Drager syndrome. 50
Relationship between insulin-like growth factor-1 system and exercise tolerance in patients with intermittent claudication. 44
In concomitant coronary and peripheral arterial disease, inflammation of the affected limbs predicts coronary artery endothelial dysfunction. 43
Totale 4.238
Categoria #
all - tutte 14.851
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.851


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021145 0 0 0 0 0 42 30 0 34 3 36 0
2021/2022251 3 0 0 2 2 6 8 8 25 9 72 116
2022/2023452 58 57 8 45 37 44 52 29 61 46 12 3
2023/2024192 6 48 29 11 8 10 0 17 4 8 32 19
2024/20251.245 73 69 1 8 84 20 114 92 101 106 477 100
2025/20261.438 258 109 273 233 453 112 0 0 0 0 0 0
Totale 4.238